T1D_stacked_color.png
Innovators From 17 Countries Vie for $250,000 in Cash and In-Kind Support to Advance Diabetes Care in the 2018 Diabetes Innovation Challenge
March 20, 2018 08:15 ET | T1D Exchange
BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- T1D Exchange, a nonprofit research and collaboration organization dedicated to accelerating novel treatments to improve the care of people living with type...
Helmsley Charitable
Helmsley Charitable Trust Announces Funding Opportunity to Advance Disruptive Technologies for Type 1 Diabetes
January 16, 2018 16:45 ET | The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Jan. 16, 2018 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program today announced a funding opportunity through the new Future...
JDRF Logo_RGB_300px_for Web doc.png
JDRF welcomes CRA review of diabetes denials
December 08, 2017 16:46 ET | Juvenile Diabetes Research Foundation Canada
TORONTO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The 300,000+ Canadians and their families living with type 1 diabetes (T1D) across the country welcome today’s announcement that the Government of Canada...
JDRF Logo_RGB_300px_for Web doc.png
Media Advisory: Canada’s leading diabetes organizations to provide an update on efforts to reverse changes to the Disability Tax Credit
December 01, 2017 17:57 ET | Juvenile Diabetes Research Foundation Canada
OTTAWA, Dec. 01, 2017 (GLOBE NEWSWIRE) -- WHAT:  Canada’s leading diabetes organizations to host a NEWS CONFERENCE to provide new information about their efforts to reverse changes in...
Patient Entrepreneur
Patient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation Award
November 08, 2017 09:14 ET | Lyfebulb
COPENHAGEN, Denmark, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Patient Entrepreneur and Founder & CEO of Med Angel BV, Amin Zayani was named the recipient of the 2017 Lyfebulb-Novo Nordisk Innovation...
Helmsley Charitable
Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes
November 06, 2017 09:00 ET | The Leona M. and Harry B. Helmsley Charitable Trust
New York, NY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for...
Patient Entrepreneur
Patient Entrepreneur Finalists Announced for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award
October 10, 2017 09:10 ET | Lyfebulb
NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- The finalists for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award have been announced today.    The Summit and Award spotlights outstanding...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
March 16, 2017 09:33 ET | The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes
March 16, 2017 09:33 ET | The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, NY and BEVERLY, MA, March 16, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust and Akston Biosciences Corporation today announced a partnership to advance...
FasterCures to Further Accelerate Biomedical Innovation with $3 Million Grant from Helmsley Charitable Trust
March 14, 2017 09:36 ET | The Leona M. and Harry B. Helmsley Charitable Trust
NEW YORK, March 14, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust has awarded FasterCures, a center of the Milken Institute, a three-year, $3 million grant to support...